earningsimpact Profile Banner
Earnings Impact Profile
Earnings Impact

@earningsimpact

Followers
1K
Following
2
Media
0
Statuses
12K

Your trusted source for Market-Hour transcripts of Earnings Calls, Business Updates, Mergers & Acquisitions FAST, ACCURATE AND FREE

Joined May 2013
Don't wanna be here? Send us removal request.
@earningsimpact
Earnings Impact
12 years
$INFI Positive outlook for the IPI-145 program from #Infinity Pharma at the Oppenheimer Annual Healthcare Conference http://t.co/AIehTlSQmu
0
0
5
@earningsimpact
Earnings Impact
12 years
$GALE Nice overview of #Galena's drugs under trial from CEO Mark Ahn @ the 2014 Leerink Swann Healthcare Conf. http://t.co/m1xrCvHIVz
0
0
1
@earningsimpact
Earnings Impact
12 years
$MHK Mohawk Industries, Inc. Q4 2013 Earnings Call Transcript @ http://t.co/dHTpmHPuUP
0
0
0
@earningsimpact
Earnings Impact
12 years
$INO “By end of this year #Inovio will have the most arsenal in our pipeline against cancer” More @ the 16th BIO Conf http://t.co/OeJXcLYMPk
0
1
1
@earningsimpact
Earnings Impact
12 years
$RNN More on #Supinoxin from Peter Suzdak of #Rexahn at the recent 16th Annual BIO CEO & Investor Conference http://t.co/NfjIH6b6Mg
0
0
1
@earningsimpact
Earnings Impact
12 years
$CYCC #Sapacitabine updates from #Cyclacel's CEO at the 16th Annual BIO CEO & Investor Conference http://t.co/x5zR6QC1GA
0
1
0
@earningsimpact
Earnings Impact
12 years
$FB “#WhatsApp is the only widely used app with a higher % of people using it daily than #Facebook itself” via the M&Acall @ Earnings Impact
0
0
0
@earningsimpact
Earnings Impact
12 years
$PRAN Nice notes from #Prana's CEO on why #each2HD would be a future boom, though just the 1st page is accessible http://t.co/spcZh4Ou5x
0
0
0
@earningsimpact
Earnings Impact
12 years
$FB Detailed reasoning behind #Facebook's #WhatsApp's buy from MZ at the acquisition call @ http://t.co/7XEag1No9S
0
0
1
@earningsimpact
Earnings Impact
12 years
$RNN Interesting points on #Supinoxin disclosed by #Rexahn CEO Peter Suzdak at the 16th Annual BIO CEO Conference http://t.co/2gq9BOYngv
0
0
0
@earningsimpact
Earnings Impact
12 years
$NAVB Updates on #Lymphoseek from #Navidea CEO Mark Pykett at the 16th Annual BIO CEO & Investor Conference http://t.co/WXaODPbhb5
0
1
0
@earningsimpact
Earnings Impact
12 years
$INO Dr. Joseph Kim on #Inovio's goal of overwhelming -signals from cancer cells at the 16th BIO CEO & Investor Conf. http://t.co/GUeyRaQqun
0
0
0
@earningsimpact
Earnings Impact
12 years
$ARNA How #Arena plans to get ahead of the curve with #BELVIQ at the 2014 Leerink Swann Global Healthcare Conference http://t.co/rLNvMp2cj6
1
1
0
@earningsimpact
Earnings Impact
12 years
More on plans for a #Facebook-like site from #Twitter @ the 2014 GS Tech. Conf. http://t.co/D1uapnVFzw
0
0
0
@earningsimpact
Earnings Impact
12 years
$ONVO Rare insight into #Organovo’s bioprinting business from CEO Keith Murphy @ Earnings Impact http://t.co/Qknfj9vbOO
0
0
0
@earningsimpact
Earnings Impact
12 years
$GALE #Abstral could hold about $400 mill worth of m-cap in revenues for #Galena @ the 16th Annual BIO CEO Conference http://t.co/cpTwUSbIdm
0
0
0
@earningsimpact
Earnings Impact
12 years
$TWTR #Twitter CEO Dick Costolo places the spotlight on new feature launches @ the 2014 Goldman Sachs Tech Conference http://t.co/Nmznb0cl3R
0
0
0
@earningsimpact
Earnings Impact
12 years
$ARIA #ARIAD's future plans for #Iclusig post getting it back on the market @ the 2014 Leerink Swann Healthcare Conf. http://t.co/lHsXbcintE
0
0
0
@earningsimpact
Earnings Impact
12 years
$AMRN More on what's lined up for #Vascepa from #Amarin's John Thero at the 2014 Leerink Swann Healthcare Conference http://t.co/ADfRTeN9u4
0
1
0
@earningsimpact
Earnings Impact
12 years
$VRNG #Vringo had offered #ZTE a license rate of $2.50 per smartphone. More from the recent investor conf. call http://t.co/2bkky92a21
0
0
0